AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(Full text of a statement. Contact details below.)
ATLANTA, Ga., Feb. 3 /PRNewswire-AsiaNet/ -- SpineVision, a leading company in innovative spinal technologies, announced today that it has entered into an Agreement with Osteotech Inc., one of the largest providers in human tissue and bone connective tissue, for the distribution of its unique range of spinal implants in the U.S. and Puerto Rico. Effective February 1, this agreement will become exclusive after a trial period of 6 months during which both companies will collaborate to further assess the full potential of these technologically advanced devices developed and clinically validated by SpineVision in the past three years.
Gerard Vanacker, founder and CEO of SpineVision, stated: "The synergies and combination of sales expertise from Osteotech with the highly innovative technologies developed by SpineVision will create a solid foundation for a dynamic growth and global presence of both companies in the strategic and highly competitive U.S. market."
Richard W. Bauer, Osteotech's President and CEO, stated: "The agreement with SpineVision is an exciting opportunity because SpineVision's products offer our sales force and ...